Brief: Syndax Pharmaceuticals Files Prospectus On Offering Up To $200 Mln Shares
26/05/2023 21:55
May 26 (Reuters) - Syndax Pharmaceuticals Inc SNDX.O :
* SYNDAX PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO
OFFERING
OF UP TO $200 MILLION SHARES OF COMMON STOCK - SEC FILING
Further company coverage: SNDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syndax Pharmaceuticals
See all newsBrief: Syndax Announces Topline Results From Maxpire Phase 2 Trial Of Axatilimab In Idiopathic Pulmonary Fibrosis
Syndax says mid-stage trial of lung disease treatment fails main goal, ends development
Syndax Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Syndax Q2 revenue jumps 92% on Revuforj, Niktimvo demand
Brief: Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million